Zogenix, Inc. To Present At Leerink Swann and Company 2014 Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that Stephen J. Farr, Ph.D., President, and Ann Rhoads, Chief Financial Officer, will be presenting at the Leerink Swann 2014 Global Healthcare Conference in New York on February 12, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news